As we step into the promising horizon of 2024, the entire BioFIT team wishes you a year of health, success and groundbreaking discoveries.

2023 was an incredible journey, and we are grateful to every member of the BioFIT community for your unwavering support, enthusiasm, and dedication to Life Sciences innovation. Together, we are improving the early-stage biotech and pharma landscapes, making meaningful connections and leading the way to a future of progress.

After 2 lively days in Marseille and a day of engaging digital networking, BioFIT 2023 has come to an end, leaving us with memories of a vibrant event!

The 12^th edition of BioFIT, Europe’s leading partnering event for early-stage deals and investment rounds in the Life Sciences field, took place in Marseille, on December 12^th and 13^th and online, on December 15^th.

With 950 international participants, BioFIT 2023 brought together a wide range of key innovation players in Life Sciences, including large biotech companies, start-ups, SMEs, academic and public research institutions, technology transfer offices and seasoned investors. 

Through insightful conferences, valuable networking, and cutting-edge innovations, this edition of BioFIT served to further push the boundaries of healthcare innovation. 

Stay tuned for more on what came out of BioFIT 2023 and what we have in store for you in 2024.

Partners: Let’s team up for Breakthroughs!

Partnerships can save lives. That’s why at Pfizer we’re eager to work with innovators to push forward great science and continually seek new partners that are actively researching bold scientific ideas, capabilities and technologies that have the potential to bring innovative treatments to patients in need. Discover Pfizer’s key areas of interest where we are looking to partner with others, and join the long history of successful partnerships with Pfizer to deliver breakthroughs that change patients’ lives

⏳ The countdown has officially begun! BioFIT, Europe’s leading partnering event for early-stage deals and investment rounds bringing together 1,000 international Life Sciences players, is just around the corner. The event kicks off next Tuesday 12^th December in Marseille, France, followed by its digital day on December 15^th. 

Don’t wait any longer to register and have the opportunity to meet with key players such as: AbbVie, AdBio partners, Andera Partners, Apollo Health Ventures, Bayer, Astellas, BIOASTER, Biofortis, Boehringer Ingelheim, CAPTECH Santé Nutrition, Charles River Laboratories, CNRS, EQT Life Sciences, EMBLEM Technology Transfer, Fund+, Eurofins, Genfit, GSK Glaxo Smith Kline, High-Tech Gründerfonds, INRAE Transfer, Ipsen, Jeito, Merck, MSD, Novo Holdings, Novo Nordisk, Pfizer, Réseau SATT, Roche, Sofinnova Partners, Spartners by Servier & Biolabs, Sterling Pharma Solutions, Thermo Fischer Scientific, Trinity College Dublin, Virbac, X’PROCHEM, Zoetis… and many more.

GENFIT is proud to support the next edition of BioFIT that will take place this year in Marseille, France, on December 12^th and 13^th, 2023.

Dear Colleagues and BioFIT delegates,

We’re excited to be back at BioFIT to meet new partners who share our passion for innovation and collaboration.

Our goal is to discover and develop breakthroughs that solve the biggest challenges in human and animal health. That starts with innovation. We’re committed to investing in and advancing emerging science. And we look forward to connecting with the biotechs, academics, TTOs and research institutions attending BioFIT to discover how we can work together to advance innovation and provide solutions to address the many areas of unmet need that remain in human and animal health.

Register on the BioFIT partnering platform to meet us in person or virtually. Our onsite meeting booth is number 67.

You can also hear from our team as they take part in key conference sessions:
Join Hervé Poulet, Director Strategic Partnering, Animal Health for the discussion on: Sourcing innovations from a more mature human health market to build assets and start-ups in animal health, on Tuesday, December 12^th, 2.00 – 3.00 pm.
Join Julie Edwards, Director of Alliance Management, for the discussion on: Best practices in managing early-stage academia-industry collaborations, on Wednesday, December 13^th, 3.30 – 4.30 pm.
We look forward to meeting you!

Servier is looking for partners

Servier is an international pharmaceutical player highly active in various collaborative approaches. Indeed, the Group is convinced that the best way to achieve fast-paced innovation oriented to meet patient needs is through collaboration and constant dialogue between those involved in health care in both the public and private sectors. That is why Servier takes an open and collaborative approach to innovation.

Partnerships

Servier has forged many alliances and is always actively looking for partnerships with world-class academic researchers, technology transfer and development offices, non-profit foundations, company builders, venture capitalists and strategic biotechnology and pharma partners.

Our partnership strategy centers around a single objective, to ramp up the speed with which we develop treatments that significantly improve patients’ quality of life. We take a people-oriented approach to our partnerships, and we focus on creating win-win situations by pooling our expertise.